Skip to main navigation menu Skip to main content Skip to site footer

Focus Topic

No 2 (2016): Life Sciences

La brevetabilité des cellules souches

  • Pierre Heuzé
Submitted
March 14, 2018
Published
March 14, 2018

Abstract

Inventions claiming stem cells are excluded from patentability in Switzerland due to the use (and the destruction) of embryos and parthenotes. Based on scientific development and the recent European case-law ICS (C-364/13) which have challenged these exclusions, this article will examine whether these Swiss exclusions are still relevant.